83 results on '"Medisch Oncologische Disciplines"'
Search Results
2. Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design(Trials, (2023), 25, 401, 10.1186/s13063-024-08223-5)
3. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months
4. Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
5. Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes
6. Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention
7. Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma
8. Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
9. Erratum: Correction: A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues (Life science alliance (2024) 7 8 PII: e202402889 DOI: 10.26508/lsa.202402730)
10. Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma
11. Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications
12. Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
13. Cox proportional hazards regression in small studies of predictive biomarkers
14. Improving sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer: A qualitative study
15. Use of automated assessment for determining associations of low muscle mass and muscle loss with overall survival in patients with colorectal cancer – A validation study
16. The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool; a validity and reliability study
17. Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study
18. The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis
19. Value of Real-World Evidence for Treatment Selection: A Case Study in Colon Cancer
20. Tumor-Infiltrating Lymphocytes in Patients with Stage i Triple-Negative Breast Cancer Untreated with Chemotherapy
21. Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma with BRCA -Like Genomic Aberrations
22. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
23. Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study
24. Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort
25. The effect of administering preprocedural VITamin K on the international normalized ratio in patients anticoagulated with ACEnocoumarol (VITKACE-study): a prospective cohort study
26. Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)
27. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group
28. Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer: less is more?
29. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer
30. A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial
31. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis
32. What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study
33. Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
34. Corrigendum to “Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer”: [Annals of Oncology 33 (2022) 769–785, (S092375342201167X), (10.1016/j.annonc.2022.05.006)]
35. High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation
36. A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide
37. Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)
38. Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial
39. Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
40. Author Correction: Possible alleviation of symptoms and side effects through clinicians’ nocebo information and empathy in an experimental video vignette study (Scientific Reports, (2022), 12, 1, (16112), 10.1038/s41598-022-19729-w)
41. Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review
42. Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study
43. Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation
44. Standardized item selection for alternate computerized versions of Rey Auditory Verbal Learning Test(-based) word lists
45. Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply
46. Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥ 70 years with ultralow risk of distant recurrence: A population-based cohort study
47. Mind your words: Oncologists' communication that potentially harms patients with advanced cancer: A survey on patient perspectives
48. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
49. BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesis
50. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.